Synthetic blood and instant runways: How biotech can benefit the warfighter

We are talking about synthetic blood, for example for treating the wounded without the need to refrigerate and transport ...

Genenta Science SPA (GNTA) Shifting from Biotech to Defense Business

Genenta Science SPA (NASDAQ:GNTA) is among the best Italian stocks to buy in 2026. Genenta Science SPA (NASDAQ:GNTA) will hold an extraordinary shareholders meeting on March 26. This comes on the back ...
Federal News Network

The BIOSECURE Act is coming, and no contractor is as “biotech‑free” as they think

O]ur companies have until June of 2028 to get there. That should not be a sigh of relief. That should be a, oh my gosh, we've ...
JD Supra

BIOSECURE Act Included In The National Defense Authorization Act

On Dec. 10, 2025, the House of Representatives passed a compromise version of the fiscal year 2026 National Defense Authorization Act (NDAA), by a vote of 312 to 112. The legislation includes the ...
Business Insider

Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator

MILAN and NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- In response to evolving market dynamics and strategic opportunities, Genenta Science S.p.A (Nasdaq: GNTA) is embarking on a strategic ...
National Academies of Sciences%2c Engineering%2c and Medicine

Biotechnology Capabilities for National Security Needs--Leveraging Advances in Transdisciplinary Biotechnology

A committee-supported project or activity that has been completed and for which output dissemination has begun. Its committee has been disbanded and closeout procedures are underway. The National ...
JD Supra

Defense Funding and Policies Set for Next Year as FY2026 NDAA Becomes Law

The scope of the FY2026 National Defense Authorization Act, now passed by the House and Senate and signed by the president on December 18, signals a deliberate push to accelerate capability delivery, ...